complicated
发表于 2025-3-21 16:12:05
书目名称Breast Disease影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0190592<br><br> <br><br>书目名称Breast Disease影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0190592<br><br> <br><br>书目名称Breast Disease网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0190592<br><br> <br><br>书目名称Breast Disease网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0190592<br><br> <br><br>书目名称Breast Disease被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0190592<br><br> <br><br>书目名称Breast Disease被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0190592<br><br> <br><br>书目名称Breast Disease年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0190592<br><br> <br><br>书目名称Breast Disease年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0190592<br><br> <br><br>书目名称Breast Disease读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0190592<br><br> <br><br>书目名称Breast Disease读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0190592<br><br> <br><br>
无政府主义者
发表于 2025-3-21 22:46:47
http://reply.papertrans.cn/20/1906/190592/190592_2.png
shrill
发表于 2025-3-22 00:34:27
http://reply.papertrans.cn/20/1906/190592/190592_3.png
nugatory
发表于 2025-3-22 04:45:15
http://reply.papertrans.cn/20/1906/190592/190592_4.png
药物
发表于 2025-3-22 12:13:21
http://reply.papertrans.cn/20/1906/190592/190592_5.png
Forsake
发表于 2025-3-22 16:00:25
http://reply.papertrans.cn/20/1906/190592/190592_6.png
牵连
发表于 2025-3-22 17:36:43
Adjuvant Systemic Therapy: Endocrine Therapyll breast cancers. Adjuvant endocrine therapy is a pivotal component of treatment for women with hormone receptor-positive early-stage breast cancer; it delays local and distant relapse and prolongs survival. Patients with ER- and/or PR-positive invasive breast cancers should be considered for adjuv
multiply
发表于 2025-3-23 00:01:56
http://reply.papertrans.cn/20/1906/190592/190592_8.png
矛盾
发表于 2025-3-23 01:47:56
Adjuvant Therapy for HER2-Positive Early Breast Cancers stories in the history of breast cancer. The development of HER-2-targeted therapies has changed the natural history of HER-2-positive breast cancer dramatically in the past two decades. Success in the metastatic setting has been subsequently translated into improved clinical outcomes for women wi
thrombus
发表于 2025-3-23 05:39:41
http://reply.papertrans.cn/20/1906/190592/190592_10.png